{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Carpesium cernuum", "Incaspitolide A", "PI3K/AKT pathway", "apoptosis", "benign prostatic hyperplasia", "cell cycle"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34100062", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["BSR20210477", "10.1042/BSR20210477"], "Journal": {"ISSN": "1573-4935", "JournalIssue": {"Volume": "41", "Issue": "6", "PubDate": {"Year": "2021", "Month": "Jun", "Day": "25"}}, "Title": "Bioscience reports", "ISOAbbreviation": "Biosci Rep"}, "ArticleTitle": "Incaspitolide A extracted from Carpesium cernuum induces apoptosis in vitro via the PI3K/AKT pathway in benign prostatic hyperplasia.", "Abstract": {"AbstractText": ["Benign prostatic hyperplasia (BPH) is a common disease that occurs mainly in older men. The pathogenesis of BPH is complex and patients face a prolonged treatment course, and novel drugs with better selectivity and lower toxicity are required. Incaspitolide A (compound TMJ-12) is a germacrane-type sesquiterpenoid compound extracted from the plant Carpesium carnuum. Extracts of C. carnuum are known to exert suppressive effects on BPH-1 cells. In the present study, we investigated the molecular mechanisms underlying the suppressive effect of TMJ-12 specifically on BPH-1 cells. A cytotoxicity assay indicated that TMJ-12 inhibited BPH-1 cell proliferation, while flow cytometry assays showed that TMJ-12 induced G2/M phase cell cycle arrest and the apoptosis of BPH-1 cells. TMJ-12 was also shown to regulate the expression of several apoptosis- and cell cycle-related proteins, namely Bcl-2, Bax, Bad, Caspase-9, Caspase-3, cyclin-dependent kinase 1 (CDK1), Cyclin B1, CDC25C, and c-Myc, among others. Collapse of the mitochondrial membrane potential (\u0394\u03a8m) following exposure to TMJ-12 was detected with the JC-1 staining assay. Further investigation revealed that treatment with TMJ-12 inhibited the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway by increasing the expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Taken together, the results suggest that TMJ-12 prevents BPH-1 cell proliferation via the PI3K/AKT pathway by inducing apoptosis and cell cycle arrest."], "CopyrightInformation": "\u00a9 2021 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedicine, Guizhou University, Guiyang 550002, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Department of Urology, Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}], "LastName": "Chen", "ForeName": "Xiaoyue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Song", "ForeName": "Jingrui", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedicine, Guizhou University, Guiyang 550002, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Urology, Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}], "LastName": "Yuan", "ForeName": "Dongbo", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Rao", "ForeName": "Qing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urology, Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}], "LastName": "Jiang", "ForeName": "Kehua", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, An Shun City People's Hospital, Anshun 561000, P.R. China."}], "LastName": "Feng", "ForeName": "Shuhui", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urology, Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}], "LastName": "Zhu", "ForeName": "Guohua", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, An Shun City People's Hospital, Anshun 561000, P.R. China."}], "LastName": "Yan", "ForeName": "Chen", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}, {"Identifier": ["0000-0002-1035-5572"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedicine, Guizhou University, Guiyang 550002, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Urology, Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}], "LastName": "Zhu", "ForeName": "Jianguo", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biosci Rep", "NlmUniqueID": "8102797", "ISSNLinking": "0144-8463"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Apoptosis Regulatory Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Cell Cycle Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Incaspitolide A"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "EC 2.7.1.137", "NameOfSubstance": "Phosphatidylinositol 3-Kinase"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 3.1.3.67", "NameOfSubstance": "PTEN Phosphohydrolase"}, {"RegistryNumber": "EC 3.1.3.67", "NameOfSubstance": "PTEN protein, human"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Apoptosis Regulatory Proteins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Asteraceae"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cell Cycle Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "enzymology", "pathology"], "DescriptorName": "Mitochondria"}, {"QualifierName": ["metabolism"], "DescriptorName": "PTEN Phosphohydrolase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinase"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["drug effects", "enzymology", "pathology"], "DescriptorName": "Prostate"}, {"QualifierName": ["drug therapy", "enzymology", "pathology"], "DescriptorName": "Prostatic Hyperplasia"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["isolation & purification", "pharmacology", "therapeutic use"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare that there are no competing interests associated with the manuscript."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "He W., Wang X., Zhan D., Li M., Wang Q., Liu J.et al. . (2021) Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate. Clin. Sci. (Lond.) 135, 167\u2013183 10.1042/CS20201283", "ArticleIdList": ["10.1042/CS20201283", "33393635"]}, {"Citation": "Hellwege J.N., Stallings S., Torstenson E.S., Carroll R., Borthwick K.M., Brilliant M.H.et al. . (2019) Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. Sci. Rep. 9, 6077 10.1038/s41598-019-42427-z", "ArticleIdList": ["10.1038/s41598-019-42427-z", "PMC6465359", "30988330"]}, {"Citation": "Langan R.C. (2019) Benign prostatic hyperplasia. Prim. Care 46, 223\u2013232 10.1016/j.pop.2019.02.003", "ArticleIdList": ["10.1016/j.pop.2019.02.003", "31030823"]}, {"Citation": "Edwards J.L. (2008) Diagnosis and management of benign prostatic hyperplasia. Am. Fam. Physician 77, 1403\u20131410", "ArticleIdList": ["18533373"]}, {"Citation": "Andriole G.L. and Kirby R. (2003) Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur. Urol. 44, 82\u201388 10.1016/S0302-2838(03)00198-2", "ArticleIdList": ["10.1016/S0302-2838(03)00198-2", "12814679"]}, {"Citation": "Thomas D., Chughtai B., Kini M. and Te A. (2017) Emerging drugs for the treatment of benign prostatic hyperplasia. Expert Opin. Emerg. Drugs 22, 201\u2013212 10.1080/14728214.2017.1369953", "ArticleIdList": ["10.1080/14728214.2017.1369953", "28829208"]}, {"Citation": "Suzuki M., Ito Y., Fujino T., Abe M., Umegaki K., Onoue S.et al. . (2009) Pharmacological effects of saw palmetto extract in the lower urinary tract. Acta Pharmacol. Sin. 30, 227\u2013281 10.1038/aps.2009.1", "ArticleIdList": ["10.1038/aps.2009.1", "PMC4002402", "19262550"]}, {"Citation": "Hennessy B.T., Smith D.L., Ram P.T., Lu Y. and Mills G.B. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4, 988\u20131004 10.1038/nrd1902", "ArticleIdList": ["10.1038/nrd1902", "16341064"]}, {"Citation": "Sun M., Hillmann P., Hofmann B.T., Hart J.R. and Vogt P.K. (2010) Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha. Proc. Natl. Acad. Sci. U.S.A. 107, 15547\u201315552 10.1073/pnas.1009652107", "ArticleIdList": ["10.1073/pnas.1009652107", "PMC2932613", "20713702"]}, {"Citation": "Fayard E., Xue G., Parcellier A., Bozulic L. and Hemmings B.A. (2010) Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway. Curr. Top. Microbiol. Immunol. 346, 31\u201356 10.1007/82_2010_58", "ArticleIdList": ["10.1007/82_2010_58", "20517722"]}, {"Citation": "Pei X.D., He Z.L., Yao H.L., Xiao J.S., Li L., Gu J.Z.et al. . (2021) 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway. Eur. J. Nutr. 10.1007/s00394-020-02440-9", "ArticleIdList": ["10.1007/s00394-020-02440-9", "33416981"]}, {"Citation": "Liu X., Powlas J., Shi Y., Oleksijew A.X., Shoemaker A.R., De Jong R.et al. . (2004) Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth. Anticancer Res. 24, 2697\u20132704", "ArticleIdList": ["15517874"]}, {"Citation": "Mills C.C., Kolb E.A. and Sampson V.B. (2018) Development of chemotherapy with cell-cycle inhibitors for adult and pediatric cancer therapy. Cancer Res. 78, 320\u2013325 10.1158/0008-5472.CAN-17-2782", "ArticleIdList": ["10.1158/0008-5472.CAN-17-2782", "PMC5771851", "29311160"]}, {"Citation": "Wendel H.G., De Stanchina E., Fridman J.S., Malina A., Ray S., Kogan S.et al. . (2004) Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428, 332\u2013337 10.1038/nature02369", "ArticleIdList": ["10.1038/nature02369", "15029198"]}, {"Citation": "Podsypanina K., Lee R.T., Politis C., Hennessy I., Crane A., Puc J.et al. . (2001) An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc. Natl. Acad. Sci. U.S.A. 98, 10320\u201310325 10.1073/pnas.171060098", "ArticleIdList": ["10.1073/pnas.171060098", "PMC56959", "11504907"]}, {"Citation": "Degraffenried L.A., Fulcher L., Friedrichs W.E., Grunwald V., Ray R.B. and Hidalgo M. (2004) Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway. Ann. Oncol. 15, 1510\u20131516 10.1093/annonc/mdh388", "ArticleIdList": ["10.1093/annonc/mdh388", "15367412"]}, {"Citation": "Zhang J.P., Wang G.W., Tian X.H., Yang Y.X., Liu Q.X., Chen L.P.et al. . (2015) The genus Carpesium: a review of its ethnopharmacology, phytochemistry and pharmacology. J. Ethnopharmacol. 163, 173\u2013191 10.1016/j.jep.2015.01.027", "ArticleIdList": ["10.1016/j.jep.2015.01.027", "25639815"]}, {"Citation": "Chung I.M., Seo S.H., Kang E.Y., Park W.H., Park S.D. and Moon H.I. (2010) Antiplasmodial activity of isolated compounds from Carpesium divaricatum. Phytother. Res. 24, 451\u2013453 10.1002/ptr.2881", "ArticleIdList": ["10.1002/ptr.2881", "19468988"]}, {"Citation": "Kun W. (2019) Study on anti-prostatic hyperplasia activity and mechanism of Carpesium cernuum. Nat. Prod. Res. Dev. 31, 517\u2013522 10.16333/j.1001-6880.2019.3.024", "ArticleIdList": ["10.16333/j.1001-6880.2019.3.024"]}, {"Citation": "Beekman A.C., Woerdenbag H.J., van Uden W., Pras N., Konings A.W., Wikstrom H.V.et al. . (1997) Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones. J. Nat. Prod. 60, 252\u2013257 10.1021/np960517h", "ArticleIdList": ["10.1021/np960517h", "9090867"]}, {"Citation": "Yan C., Zhang W.-Q., Sun M., Liang W., Wang T.-Y., Zhang Y.-D.et al. . (2018) Carpescernolides A and B, rare oxygen bridge-containing sesquiterpene lactones from Carpesium cernuum. In Tetrahedron Letters 59, 4063\u20134066"}, {"Citation": "Zhang Y., Yang J., Wen Z., Chen X., Yu J., Yuan D.et al. . (2020) A novel 3\u2032,5\u2032-diprenylated chalcone induces concurrent apoptosis and GSDME-dependent pyroptosis through activating PKCdelta/JNK signal in prostate cancer. Aging (Albany N.Y.) 12, 9103\u20139124 10.18632/aging.103178", "ArticleIdList": ["10.18632/aging.103178", "PMC7288973", "32427575"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S.et al. . (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 10.1002/jcc.21256", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Trott O. and Olson A.J. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Bender C.E., Fitzgerald P., Tait S.W., Llambi F., Mcstay G.P., Tupper D.O.et al. . (2012) Mitochondrial pathway of apoptosis is ancestral in metazoans. Proc. Natl. Acad. Sci. U.S.A. 109, 4904\u20134909 10.1073/pnas.1120680109", "ArticleIdList": ["10.1073/pnas.1120680109", "PMC3324028", "22416118"]}, {"Citation": "Mayer I.A. and Arteaga C.L. (2016) The PI3K/AKT pathway as a target for cancer treatment. Annu. Rev. Med. 67, 11\u201328 10.1146/annurev-med-062913-051343", "ArticleIdList": ["10.1146/annurev-med-062913-051343", "26473415"]}, {"Citation": "Sun X.M., Macfarlane M., Zhuang J., Wolf B.B., Green D.R. and Cohen G.M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053\u20135060 10.1074/jbc.274.8.5053", "ArticleIdList": ["10.1074/jbc.274.8.5053", "9988752"]}, {"Citation": "Yan T., Wang X., Wei G., Li H., Hao L., Liu Y.et al. . (2021) Exosomal miR-10b-5p mediates cell communication of gastric cancer cells and fibroblasts and facilitates cell proliferation. J. Cancer 12, 2140\u20132150 10.7150/jca.47817", "ArticleIdList": ["10.7150/jca.47817", "PMC7974515", "33754012"]}, {"Citation": "Harvey A.L., Edrada-Ebel R. and Quinn R.J. (2015) The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111\u2013129 10.1038/nrd4510", "ArticleIdList": ["10.1038/nrd4510", "25614221"]}, {"Citation": "Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F.et al. . (2003) Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2, 65\u201372", "ArticleIdList": ["12533674"]}, {"Citation": "Zhang T., Si J.G., Zhang Q.B., Ding G. and Zou Z.M. (2016) New highly oxygenated germacranolides from Carpesium divaricatum and their cytotoxic activity. Sci. Rep. 6, 27237 10.1038/srep27237", "ArticleIdList": ["10.1038/srep27237", "PMC4893730", "27265755"]}, {"Citation": "Green D.R. (2019) The coming decade of cell death research: five riddles. Cell 177, 1094\u20131107 10.1016/j.cell.2019.04.024", "ArticleIdList": ["10.1016/j.cell.2019.04.024", "PMC6534278", "31100266"]}, {"Citation": "Chipuk J.E. and Green D.R. (2005) Do inducers of apoptosis trigger caspase-independent cell death? Nat. Rev. Mol. Cell Biol. 6, 268\u2013275 10.1038/nrm1573", "ArticleIdList": ["10.1038/nrm1573", "15714200"]}, {"Citation": "Deng J. (2017) How to unleash mitochondrial apoptotic blockades to kill cancers? Acta Pharm. Sin. B. 7, 18\u201326 10.1016/j.apsb.2016.08.005", "ArticleIdList": ["10.1016/j.apsb.2016.08.005", "PMC5237704", "28119805"]}, {"Citation": "Perdiguero E. and Nebreda A.R. (2004) Regulation of Cdc25C activity during the meiotic G2/M transition. Cell Cycle 3, 733\u2013737 10.4161/cc.3.6.906", "ArticleIdList": ["10.4161/cc.3.6.906", "15136768"]}, {"Citation": "Wang T., Liu C. and Jia L. (2018) The roles of PKCs in regulating autophagy. J. Cancer Res. Clin. Oncol. 144, 2303\u20132311 10.1007/s00432-018-2731-4", "ArticleIdList": ["10.1007/s00432-018-2731-4", "30116883"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "3"}, {"Year": "2021", "Month": "6", "Day": "1"}, {"Year": "2021", "Month": "6", "Day": "2"}, {"Year": "2021", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "8", "Hour": "6", "Minute": "54"}, {"Year": "2021", "Month": "6", "Day": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34100062", "PMC8220449", "10.1042/BSR20210477", "228962"]}}], "PubmedBookArticle": []}